Fitusiran: Advancing Hemophilia Prophylaxis and Patient Care

This presentation provides an informative overview of fitusiran prophylaxis, exploring hemophilia types, shortcomings of current treatments, and fitusiran's role in addressing these challenges. It delves into the ATLAS-PPX trial design, including objectives, participant criteria, and outcomes evaluated. Key findings on efficacy, quality of life improvements, and safety are discussed, highlighting the future implications for advancing hemophilia care.